Recent publications have seemed to clarify the controversies that existed in the diagnosis of laryngopharyngeal reflux and have shed light on the therapy. The present article reviews recent publications in the diagnosis and management of laryngopharyngeal reflux.
Introduction
Laryngopharyngeal reflux (LPR) has been suggested as a term for the association of laryngeal disorders and gastroesophageal reflux disease (GERD) [1] . Soon after this association was noticed [2], LPR was defined as being a different disease from GERD [3] , in that LPR tends to occur during the daytime, in the upright position, and is not associated with obesity [4] , in contrast with GERD. LPR is a chronic disease with exacerbations and remissions [3] .
Although some patients have both LPR and GERD, most patients with LPR do not have GERD [3] , so that laryngopharyngeal symptoms can be the sole manifestation of reflux disease [3, 5] . The diagnosis of LPR is challenging because symptoms and physical findings lack sufficient specificity to confirm LPR and to rule out other conditions that may also cause them [6] . Monitoring of pH is less reliable in confirming LPR than GERD [7] . Variability in testing methods and lack of agreement on normative values cause doubt about the sensitivity of pH-monitoring studies [7] . General agreement exists on empiric treatment of LPR symptoms, with proton-pump inhibitors (PPI) recommended for between 2 and 6 months [8 •• ,9 •• ]. Response to PPI therapy is highly variable [3, 10, 11] and symptom response precedes improvement of signs in laryngoscopy [3] . High rates of treatment failure, in return, require the diagnosis to be verified and call the pathophysiology of LPR into question. Reflux of gastric contents is a major cause of laryngeal pathology [1] . Factors that make the laryngeal tissue susceptible to acid, however, remain uncertain.
Clinical criteria
The most common clinical presentations of LPR include hoarseness, chronic cough, throat clearing, postnasal drip, sore throat, and globus sensation [3, 5] . Dysphagia and breathing difficulties have also been reported [3, 5, 12, 13] . The reduced laryngopharyngeal sensitivity can result in an increased risk of aspiration [12] . Other manifestations in the head and neck that have been reported include sinusitis and otitis media [14] .
Laryngoscopic abnormalities are frequently confined to the posterior larynx and include the mucosa overlying the arytenoid cartilages, the interarytenoid region, and the posterior third of the vocal cords [15, 16] .
Edema and erythema involving the mucosa over arytenoids and interarytenoid cobblestoning are common signs in LPR [5,9 •• ,13,15,17] .
On vocal cords, edema, ranging from mild swelling to polypoid degeneration (also called Reinke edema), granulomas, erythema, leukoplakia, nodules, and polyps often develop [5, 15, 17] .
The significance of several signs reported in LPR is uncertain. Among them, posterior glottic erythema is not more likely to be associated with reflux, when compared with diffuse erythema [15, 18] . Interarytenoid bars, arytenoid medial wall erythema, posterior pharyngeal wall cobblestoning, posterior cricoid wall edema, or pseudosulcus vocalis are also noticed in the healthy population [6, 11, 19] .
Recent studies do not provide additional information on symptoms and signs of LPR. As variable definitions imply, accurate clinical assessment of laryngeal involvement in LPR is difficult. Laryngeal physical findings cannot be reliably determined [20] . Consequently, the reflux symptom index (RSI) and reflux finding score (RFS) developed by Belafsky et al. [21] are used to diagnose, assess severity, and document benefits of therapeutic interventions in patients with LPR [22] . Among items on the grading scale, supraglottic, glottic, and subglottic edema and erythema were thought to be useful for assessing the presence of LPR by digitally stored videostroboscopic examinations [23] .
Carrau et al. [24 • ] recently established and validated a new, disease-specific assessment tool, the quality-oflife instrument for LPR (LPR-HRQL), to assess patient-reported outcomes with regard to health-related quality of life of patients with LPR (Table 1) . This tool allows the assessment of the response to existing and/or new therapies of LPR patients in clinical practice as well as in research [24 • ].
Immunoassay
In LPR, demonstration of the increased electrophysiological protective reflex of the cricopharyngeal sphincter [16] , the impaired sensitivity of the laryngopharynx [12] , the decreased concentration of salivary epidermal growth factor [25] together with the detection of H + /K + -ATPase (proton) pump in seromucinous cells and ducts [26 • ], the decreased protective carbonic anhydrase III, and the detection of pepsin in the human larynx [27 •• ] indicated, that the laryngeal mucosa, exposed to the irritation of the acid, additionally loses its defense-and-repair mechanisms. Another recent study investigated the detection of pepsin in the laryngeal mucosa, and this method promises an evolution in the diagnosis of LPR. Knight et al.
[28 •• ] tried to determine whether measurement of pepsin in throat sputum by immunoassay could be used to diagnose LPR. Pepsinassay results from 63 throat sputum samples obtained from 23 patients with clinical LPR were compared with their pH-monitoring data for detecting reflux events (pH < 4). The pepsin immunoassay was 100% sensitive and 89% specific for LPR. Detection of pepsin in throat sputum by immunoassay appeared to provide a sensitive, easy method to detect LPR [28 •• ].
pH monitoring
Harrell et al. [29] designed a new pH-monitoring protocol in patients with suspected LPR so that the locations of pH sensors could maximize the yield in detecting abnormal acid reflux. They determined the distribution of esophageal lengths in 1043 subjects undergoing esophageal manometry and found that, in 92% of the study population, a single-probe triple-sensor pH catheter with 3-15, 6-15, and 9-15 sensor spacing would satisfactorily locate the sensors in the hypopharynx and in the proximal and distal esophagus. When the triple-sensor combination was compared with dual esophageal sensors, an abnormal pH test was found in 98% and 71% of LPR patients, respectively. Adding a hypopharyngeal sensor increased the detection of abnormal acid reflux [29] .
The most recent information on pH monitoring was acquired by the meta-analysis of upper-probe measurements in normal subjects and in patients with LPR [30 •• ]. The authors studied 529 patients with LPR and 264 normal subjects included in 16 studies. Positive events in all studies were reflux of gastric contents of a pH of 4 or less to the pharynx. Acid exposure time (AET) had no detectable or measurable acid exposure in normal subjects when the upper probe was placed 1.5-2 cm above the upper esophageal sphincter (UES) and AET was 0.01% when the upper probe was in the UES. The number of reflux events was also slightly more when the upper probe was placed at the UES than when 2 cm above the UES. The authors concluded that the upper probe gave accurate and consistent information in patients with LPR when placed in the zone between the UES and 2 cm into the hypopharynx. AET percentage was very reliable in differentiating normal subjects from patients with LPR. The technology and methodology of probe testing was found to be quite reliable and was consistent on a worldwide basis [30 •• ] .
Several studies suggested that laryngeal damage occurs at pH 5 or greater and a pH of 5 could be appropriate as a cutoff level [7,28 •• ].
The multichannel intraluminal impedance (MII) technology allows identification of acid as well as nonacid reflux material, adds useful information about the volume and pH of reflux material, and improves diagnostic accuracy for describing LPR events, confirming their relation to the symptoms [8, 31] ; its use, however, is unfortunately limited as it is not available on a worldwide basis. The recently developed wireless pH-monitoring system allows precise placement of the pH transducer, and has been effective in some adults who fail to tolerate an external catheter [32] . Novel techniques such as oropharyngoesophageal scintigraphy [33] , barium-swallowing studies [12] , and transnasal esophagoscopy [18] can add reliable information in patients with suspected reflux disease, although not in high rates.
Treatment
A prospective cohort study evaluated the optimal dose and duration of medical therapy [9 •• ]. The effectiveness of lansoprazole 30 mg twice daily, omeprazole 20 mg twice daily and ranitidine 300 mg, or esomeprazole 40 mg once daily was evaluated in three groups of patients with LPR. The overall response rate for all three groups was 70%. PPI twice daily was more effective than PPI once daily. More response was achieved at 4 months compared with 2 months. Therefore, the authors concluded that aggressive acid suppression with twice-daily PPI for at least 4 months is warranted for treatment of LPR [9 •• ]. Interarytenoid mucosa and vocal-cord abnormalities suggested better symptom response to treatment [9 •• ]. This study, although not placebo controlled, demonstrates that LPR requires longterm aggressive acid-suppression therapy with PPI and that adding H2-receptor antagonists does not result in better symptom response. The duration of the medical therapy, however, has not yet been adequately clarified.
When medical management fails, patients with demonstrable high-volume liquid reflux and lower sphincter incompetence are often candidates for surgical intervention. Before surgical intervention, fundoplication, or a laparoscopic approach, care must be paid to confirm the diagnosis of LPR because of poor surgical outcome in patients unresponsive to medical therapy [8 •• ]. Endoscopic treatment, the radiofrequency approach, has been recently introduced as a new option for treating GERD [34, 35] . It can be considered in the treatment of refluxrelated upper-airway diseases [34] . Protocols for the diagnosis and management of LPR recommend initial empiric high-dose, long-term PPI therapy and reassessment of the diagnosis by pH monitoring including MII technology in nonresponders to therapy [8 •• ,22] . The duration of maintenance therapy, side effects of long-term use, noncompliance with drug therapy, and when to disclose surgical therapy, however, has not yet been determined [36] .
The effects of a voice therapy program in patients who had failed medical and surgical treatments for vocal process granuloma related to LPR were evaluated in a recent study [37 • ]. The primary treatment objective was to modify each patient's vocal-cord contact pattern so that a small gap remained between the vocal processes during voicing. A phonoscopic approach was used, so that the clinician and the patient were able to observe the larynx endoscopically while also listening to the voice. Of the 10 patients who underwent therapy, eight were able to achieve the treatment objective, and all eight experienced resolution of pathology or a marked reduction in its extent. Almost always laryngeal lesion persisted while symptoms recovered, at least par-tially [37 • ]. The treatment program described might be of value to similar patients with resistant granuloma related to extraesophageal reflux [37 • ]. Voice disturbances represent the major chief complaint in patients who professionally use their voice and they require specific management in addition to medical and surgical therapy [36,37 • ].
Conclusion
In LPR, laryngeal pathology results from small amounts of acid causing damage to laryngeal tissues and producing localized symptoms. In patients presenting with characteristic symptoms due to the irritation of the laryngeal mucosa, LPR should be remembered after exclusion of other factors that might also cause the symptoms.
In the diagnosis and management of patients suspected of having LPR, we propose the algorithm as in Fig. 1 , including the information obtained from current research. No symptom or sign is recognized to be pathognomonic to LPR. In laryngoscopy, abnormalities involving vocal cords, arythenoids, and interarythenoid mucosa, particularly edema on these sites, is related to LPR. We believe that detailed, accurate evaluation and Surgical interventions are mainly based on the treatment of coexisting GERD. Poor outcomes are generally regarded as a consequence of poor diagnostic criteria and currently limit the recommendation of surgical fundoplication in patients unresponsive to medical therapy. The endoscopic radiofrequency approach is a novel therapeutic method, but the outcomes are not yet elucidated.
The clarification of therapeutic measures in LPR needs further evaluation with attention to randomization and the blinding process, including placebo-controlled patient groups, taking symptom and sign severity into consideration, to establish the exact duration of medical therapy and the indication of surgical intervention with reference to patients with GERD and without GERD.
